Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
6/13/25 Swedish Orphan Biovitrum (SOBI) Gamifant for Histiocytosis Subscribers Only Subscribers Only Subscribers Only
6/11/25 argenx (ARGX) Vyvgart for Sjogren's Disease Subscribers Only Subscribers Only Subscribers Only
6/11/25 Bristol (BMY) Sotyktu for Psoriatic Arthritis (PsA) Subscribers Only Subscribers Only Subscribers Only
6/9/25 PolyPid (PYPD) D-PLEX for Intra-Abdominal Infections (Antibacterial) Subscribers Only Subscribers Only Subscribers Only
6/9/25 Merck & Co (MRK) MK-0616 for Dyslipidemia / Hypercholesterolemia Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
04/01/2025 Subscribers Only Subscribers Only Company - Divestment/Spinoff
04/24/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
05/20/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
05/22/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/02/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update